Faeth Therapeutics, Inc. Capital Expenditures
Faeth Therapeutics, Inc. (FTH) reported Capital Expenditures of $6.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-04
- Faeth Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Faeth Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $6.00K.
- Faeth Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00.
- Faeth Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
- Faeth Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $16.00K, a 89.04% decline from fiscal 2024.
- Faeth Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $146.00K, a 18.89% decline from fiscal 2023.
- Faeth Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $180.00K, a 43.93% decline from fiscal 2022.
- Faeth Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $321.00K, a 84.16% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $6.00K 10-Q · filed 2026-08-04 | $6.00K derived: sum of 3 quarters · filed 2026-08-04 | $6.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $6.00K 10-Q · filed 2026-05-15 | $6.00K derived: sum of 2 quarters · filed 2026-05-15 | $6.00K derived: sum of 3 quarters · filed 2026-05-15 | $22.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $16.00K derived: sum of 3 quarters · filed 2026-08-04 | $16.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $16.00K derived: sum of 2 quarters · filed 2026-08-04 | $16.00K 10-Q · filed 2025-11-14 | $16.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $16.00K 10-Q · filed 2026-08-04 | $16.00K derived: sum of 3 quarters · filed 2026-08-04 | $16.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $0.00 derived: sum of 3 quarters · filed 2026-05-15 | $109.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $109.00K derived: sum of 3 quarters · filed 2026-03-30 | $146.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $109.00K derived: sum of 2 quarters · filed 2025-11-14 | $146.00K 10-Q · filed 2025-11-14 | $146.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $109.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $146.00K 10-Q · filed 2025-08-05 | $146.00K derived: sum of 3 quarters · filed 2025-08-05 | $146.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $37.00K 10-Q · filed 2025-05-06 | $37.00K derived: sum of 2 quarters · filed 2025-05-06 | $37.00K derived: sum of 3 quarters · filed 2025-05-06 | $66.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $0.00 derived: sum of 2 quarters · filed 2025-03-28 | $29.00K derived: sum of 3 quarters · filed 2025-03-28 | $180.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $29.00K derived: sum of 2 quarters · filed 2024-11-14 | $180.00K 10-Q · filed 2024-11-14 | $180.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $180.00K 10-Q · filed 2024-08-06 | $180.00K derived: sum of 3 quarters · filed 2024-08-06 | $430.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $151.00K 10-Q · filed 2024-05-09 | $151.00K derived: sum of 2 quarters · filed 2024-05-09 | $401.00K derived: sum of 3 quarters · filed 2024-05-09 | $453.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $250.00K derived: sum of 2 quarters · filed 2024-02-29 | $302.00K derived: sum of 3 quarters · filed 2024-02-29 | $321.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $302.00K derived: sum of 2 quarters · filed 2023-11-07 | $321.00K 10-Q · filed 2023-11-07 | $856.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $71.00K 10-Q · filed 2023-08-03 | $606.00K derived: sum of 3 quarters · filed 2023-08-03 | $994.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $19.00K 10-Q · filed 2023-05-09 | $554.00K derived: sum of 2 quarters · filed 2023-05-09 | $942.00K derived: sum of 3 quarters · filed 2023-05-09 | $1.56M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $923.00K derived: sum of 2 quarters · filed 2023-03-29 | $1.54M derived: sum of 3 quarters · filed 2023-03-29 | $2.03M 10-K · filed 2023-03-29 |
| 2021-09-30 | $388.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.00M derived: sum of 2 quarters · filed 2022-11-08 | $1.49M 10-Q · filed 2022-11-08 | $1.81M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $616.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.10M 10-Q · filed 2022-08-09 | $1.42M derived: sum of 3 quarters · filed 2022-08-09 | $2.25M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $487.00K 10-Q · filed 2022-05-10 | $803.00K derived: sum of 2 quarters · filed 2022-05-10 | $1.64M derived: sum of 3 quarters · filed 2022-05-10 | $1.64M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.15M derived: sum of 2 quarters · filed 2022-03-15 | $1.15M derived: sum of 3 quarters · filed 2022-03-15 | $1.21M 10-K · filed 2022-03-15 |
| 2020-09-30 | $836.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $838.00K derived: sum of 2 quarters · filed 2021-11-10 | $890.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $54.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $52.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |